• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毒理基因组学、药物研发与病理学家。

Toxicogenomics, drug discovery, and the pathologist.

作者信息

Boorman Gary A, Anderson Steven P, Casey Warren M, Brown Roger H, Crosby Lynn M, Gottschalk K, Easton Marilyn, Ni Hong, Morgan Kevin T

机构信息

Laboratory for Experimental Pathology, Environmental Toxicology Program, NIEHS, Research Triangle Park, NC 27709, USA.

出版信息

Toxicol Pathol. 2002 Jan-Feb;30(1):15-27. doi: 10.1080/01926230252824671.

DOI:10.1080/01926230252824671
PMID:11890469
Abstract

The field of toxicogenomics, which currently focuses on the application of large-scale differential gene expression (DGE) data to toxicology, is starting to influence drug discovery and development in the pharmaceutical industry. Toxicological pathologists, who play key roles in the development of therapeutic agents, have much to contribute to DGE studies, especially in the experimental design and interpretation phases. The intelligent application of DGE to drug discovery can reveal the potential for both desired (therapeutic) and undesired (toxic) responses. The pathologist's understanding of anatomic, physiologic, biochemical, immune, and other underlying factors that drive mechanisms of tissue responses to noxious agents turns a bewildering array of gene expression data into focused research programs. The latter process is critical for the successful application of DGE to toxicology. Pattern recognition is a useful first step, but mechanistically based DGE interpretation is where the long-term future of these new technologies lies. Pathologists trained to carry out such interpretations will become important members of the research teams needed to successfully apply these technologies to drug discovery and safety assessment. As a pathologist using DGE, you will need to learn to read DGE data in the same way you learned to read glass slides, patiently and with a desire to learn and, later, to teach. In return, you will gain a greater depth of understanding of cell and tissue function, both in health and disease.

摘要

毒理基因组学领域目前专注于将大规模差异基因表达(DGE)数据应用于毒理学,正开始影响制药行业的药物发现和开发。毒理病理学家在治疗药物的开发中发挥着关键作用,对DGE研究有很大贡献,尤其是在实验设计和解释阶段。将DGE智能应用于药物发现可以揭示预期(治疗)和非预期(毒性)反应的可能性。病理学家对驱动组织对有害剂反应机制的解剖学、生理学、生物化学、免疫学和其他潜在因素的理解,将一系列令人困惑的基因表达数据转化为重点研究项目。后一过程对于DGE在毒理学中的成功应用至关重要。模式识别是有用的第一步,但基于机制的DGE解释才是这些新技术的长期未来所在。经过培训能够进行此类解释的病理学家将成为成功将这些技术应用于药物发现和安全评估所需研究团队的重要成员。作为一名使用DGE的病理学家,你需要学会像学习阅读玻片一样阅读DGE数据,耐心且有求知欲,之后还要传授知识。作为回报,你将对健康和疾病状态下的细胞和组织功能有更深入的理解。

相似文献

1
Toxicogenomics, drug discovery, and the pathologist.毒理基因组学、药物研发与病理学家。
Toxicol Pathol. 2002 Jan-Feb;30(1):15-27. doi: 10.1080/01926230252824671.
2
Complementary roles for toxicologic pathology and mathematics in toxicogenomics, with special reference to data interpretation and oscillatory dynamics.毒理病理学与数学在毒理基因组学中的互补作用,特别涉及数据解读与振荡动力学
Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:13-25. doi: 10.1080/01926230490424789.
3
The promise of toxicogenomics.毒理基因组学的前景。
Curr Opin Mol Ther. 2002 Jun;4(3):229-35.
4
Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.“毒理基因组学”新时代的毒理学与遗传毒理学:“组学”技术的影响
Mutat Res. 2002 Jan 29;499(1):13-25. doi: 10.1016/s0027-5107(01)00292-5.
5
State-of-the-art genomics approaches in toxicology.毒理学中的最新基因组学方法。
Mutat Res. 2010 Dec;705(3):165-71. doi: 10.1016/j.mrrev.2010.04.007. Epub 2010 May 11.
6
Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data.毒理基因组学在毒理学中的应用:微阵列数据分析的基本概念
Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:72-83. doi: 10.1080/01926230490424752.
7
Novel and future applications of microarrays in toxicological research.微阵列在毒理学研究中的新应用及未来应用
Expert Opin Drug Metab Toxicol. 2007 Aug;3(4):599-608. doi: 10.1517/17425225.3.4.599.
8
Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.毒理学中基因组学数据的当前和未来应用:监管应用的机遇和挑战。
Regul Toxicol Pharmacol. 2011 Nov;61(2):141-53. doi: 10.1016/j.yrtph.2011.07.012. Epub 2011 Aug 5.
9
Strategic importance of research support through pathology.通过病理学提供研究支持的战略重要性。
Toxicol Pathol. 2002 Jan-Feb;30(1):4-7. doi: 10.1080/01926230252824644.
10
A Historical View and Vision into the Future of the Field of Safety Pharmacology.安全药理学领域的历史回顾与未来展望
Handb Exp Pharmacol. 2015;229:3-45. doi: 10.1007/978-3-662-46943-9_1.

引用本文的文献

1
Pathological bases for a robust application of cancer molecular classification.癌症分子分类稳健应用的病理基础。
Int J Mol Sci. 2015 Apr 17;16(4):8655-75. doi: 10.3390/ijms16048655.
2
The role of the toxicologic pathologist in the post-genomic era(#).毒理病理学家在基因组学后时代的作用(#)
J Toxicol Pathol. 2013 Jun;26(2):105-10. doi: 10.1293/tox.26.105. Epub 2013 Jul 10.
3
Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.尽管临床前研究结果不利,但药物研发仍取得成功 第1部分:解决问题的流程及最重要的发现
J Toxicol Pathol. 2010 Dec;23(4):189-211. doi: 10.1293/tox.23.189. Epub 2010 Dec 16.
4
Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles.基于时间进程基因表达谱预测药物的药理和外源物质反应。
PLoS One. 2009 Dec 2;4(12):e8126. doi: 10.1371/journal.pone.0008126.
5
Modern classification of neoplasms: reconciling differences between morphologic and molecular approaches.肿瘤的现代分类:调和形态学与分子学方法之间的差异。
BMC Cancer. 2005 Aug 10;5:100. doi: 10.1186/1471-2407-5-100.
6
Accelerating drug discovery.加速药物研发。
EMBO Rep. 2004 Sep;5(9):837-42. doi: 10.1038/sj.embor.7400236.
7
Rapid analysis of gene expression changes caused by liver carcinogens and chemopreventive agents using a newly developed three-dimensional microarray system.使用新开发的三维微阵列系统快速分析肝脏致癌物和化学预防剂引起的基因表达变化。
Cancer Sci. 2004 Feb;95(2):123-30. doi: 10.1111/j.1349-7006.2004.tb03192.x.